$COST

Costco Q3 Preview: Stock Could Hit $1,200 Or Fall To $960, Market Expert Says 'Prudent To Wait This One O

Analysts expect Costco to report Q3 revenue of $69.42B (vs. $63.2B) and EPS of $4.92 (vs. $4.28), according to Benzinga Pro. Oppenheimer’s Rupesh Parikh raised its price target to $1,160 and kept an Outperform rating. JPMorgan said Costco is up to 60% cheaper than traditional grocery. Placer.ai data showed Costco visits rose 6.6% in Feb, 4.4% in Mar, and 7.2% in Apr. Shares were about $1,003.69.

Original reporting
Published May 27, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Costco Q3 Preview: Stock Could Hit $1,200 Or Fall To $960, Market Expert Says 'Prudent To Wait This One O — source image
Decision brief

The 30-second read

$COSTNeutralHigh
01

Why it matters

Trading focus is the dispersion between an optimistic scenario (move above resistance toward ~$1,200) and a weak-reaction scenario (pressure toward ~$960, with ~$870 as deeper support).

02

Market read

Pre-earnings positioning is driven by (1) value proposition and potential membership tailwinds, (2) gas-price-related visit strength, and (3) a wide technical reaction range.

03

What to watch

The article emphasizes gas-price-driven visits, but it doesn’t quantify whether higher gas traffic converts into sustained membership renewals or higher gross margin in the quarter.

Relevance 9/10Timing: High—article is a pre-earnings setup for Costco’s Q3 report with explicit upside/downside technical levels.

Background

The piece previews Costco’s upcoming Q3 earnings using consensus estimates, analyst commentary, peer results (BJ’s and Sam’s Club), and foot-traffic data (Placer.ai) tied to elevated gas prices.

Company-level read

Ticker impact

$COSTNeutralMedium confidence
Context

Costco Q3 preview centers on EPS/revenue expectations, analyst target changes, and technical levels/support/resistance that could drive post-earnings moves.

Expected impact

Expect a volatile reaction window; upside case targets a move above ~$1,050 toward ~$1,200, while a weak report could pressure toward ~$960 support.

Evidence & confidence

Article cites raised Oppenheimer target and positive visit/gas-traffic trends, but also warns shares are testing major resistance and highlights explicit downside support levels.

$BJBullishLow confidence
Context

BJ’s results are cited as strong membership growth and grocery traffic, potentially improving the read-across for Costco’s upcoming quarter.

Expected impact

Limited direct catalyst for BJ’s beyond sentiment; near-term trading likely tracks peer/sector momentum into Costco’s print.

Evidence & confidence

The article uses BJ’s as a leading indicator for Costco, not as a new BJ’s-specific catalyst beyond already-reported Q1 figures.

$WMTNeutralLow confidence
Context

Walmart is mentioned as owner of Sam’s Club, whose Q1 sales and comparable growth are used as additional read-across for warehouse-club demand.

Expected impact

Minimal direct price impact expected for WMT; any effect would be through broader retail sentiment around warehouse clubs.

Evidence & confidence

No Walmart financial update is provided—only Sam’s Club read-through and peer context.

Market effects

Warehouse-club demand appears supported by membership growth and elevated gas-station visits, reinforcing the value/bulk-buy narrative across the group.

No explicit regional breakdown; impact is framed as broad US consumer behavior toward value and bulk buying.

Low—story is US retail/warehouse-club traffic and membership dynamics with no international catalyst mentioned.

Counterpoint

Even with strong traffic and peer prints, Costco’s stock could sell off if margin, membership economics, or guidance disappoint—technical resistance may amplify profit-taking.

Key entities

  • Costco Wholesale

    Upcoming Q3 earnings preview with consensus EPS/revenue, analyst target change, and technical support/resistance levels.

  • BJ’s Wholesale

    Peer read-through via reported membership growth/traffic strength used to infer Costco’s quarter.

  • Sam’s Club

    Peer read-through via Q1 net sales/comparable sales and membership/renewal metrics.

  • Walmart

    Owner of Sam’s Club; included only as the corporate link to the peer read-through.

Related articles

$NKEMed

Trump’s Invalidated Tariffs Trigger $100 Billion in Corporate Refunds

The U.S. Supreme Court invalidated President Trump’s “Liberation Day” tariffs under the IEEPA. According to U.S. Customs and Border Protection, about $100 billion in tariff refunds, including interest, has been certified and sent to Treasury for disbursement. CBP collected about $166 billion, and refunds are flowing to importers such as Nike, Walmart, Apple, Ford, Nintendo, and Amazon.

$CEGMedAI 8/10

Constellation Signed 920 Megawatts of New Power Deals, Including a Walmart PPA. Here's What It Means for CEG Stock.

Constellation Energy (CEG) said it signed 920 MW of long-term power purchase agreements in Q2, including a 176 MW deal with Walmart (WMT) for two 15-year terms starting in 2029 and 2030. CEG reported Q2 adjusted earnings of $2.55 per share versus $1.91 a year earlier and guided 2026 base EPS of $11.50 to $12.50, projecting 20% annualized growth through 2029.

$WMTMed

Walmart sued over alleged voiceprint collection from customer calls

Walmart Inc. is named in a proposed class action filed in Illinois federal court alleging it secretly converts customer call audio into biometric voiceprints using AI without written consent under the Illinois Biometric Information Privacy Act. Plaintiffs seek class certification, injunctive relief, destruction/return of data, attorneys’ fees, and BIPA damages of $1,000 or $5,000 per violation.

$AMZNMed

Amazon, CVS And Walmart Race To Fill $50 Weight

Amazon said its pharmacy will distribute eligible Medicare patients’ GLP-1 weight-loss drugs for $50 per month under the Medicare GLP-1 Bridge Program launched July 1. The program shifts financial risk to CMS for 18 months. The article cites drug price cuts up to 97% from peak levels and notes Eli Lilly and Novo Nordisk list prices of about $199 to $499 outside Medicare.